Abstract
Introduction
Breast cancer (BC), the second most common malignant tumor in women worldwide ( Figure 1 ) [1] . Many etiological factors such as a wide spectrum of clinical manifestations caused by family clustering, hormonal factors, lactation, early menarche, metabolic and secretory factors, obesity, dietary factors, alcohol consumption, smoking, and lose-dose irradiation [3] . On top of that, obesity, alcoholism, and tobacco smoking were found to result in this incidence [4] [5] [6] . Many of the established risk factors are linked to estrogens. The risk is increased by early menarche, late menopause, and obesity in postmenopausal women, and prospective studies have shown that high concentrations of endogenous estradiol are associated with an increase in risk [7] .
Childbearing reduces risk, with greater protection for early first birth and a larger number of births; breastfeeding probably has a protective effect. Both oral contraceptives and hormonal therapy for menopause cause a small increase in breast-cancer risk, which appears to diminish once use stops. Alcohol increases risk, whereas physical activity has been suggested as protective. Mutations in certain genes greatly increase breast cancer risk, but these account for a minority of cases. The natural therapeutic (i.e. nutritional supplements) are still discovering in progress to prevent the unnecessary aggressive procedures, although there are many FDA-approval drugs for breast cancers [8, 9] .
Tumors are heterogeneous, and an individual has inherited different genetic background. Thus, it is hard to find an effective treatment and it may recurrent after recovery from first treatment.
Obesity accelerate the worse the breast cancer
The proportion of obesity has been distributed various within United State ( Figure 2 ). Obesity is known as a key contributory factor associated with cancer risk and mortality. Obesity has resulted from increased cells accumulated lipids and slowly differentiated into mature adipocytes. The study has shown the correlation obesity with breast cancer. Obese patients have a higher ratio of crown-like structures accumulated in the mammary adipose tissue which release cytokines as a sub-inflammation [10] .
Furthermore, the crown-like structure in the mammary adipose tissue was positively associated with biomarkers for lipid deposition (i.e. triglyceride/highdensity lipoprotein-cholesterol ratio), inflammation (i.e. serum c-reactive protein), glucose (i.e. glycated
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Moreover, other study had demonstrated that adipocyteassociated lung neutrophilia and subsequent exacerbate the stimulatory effects of a primary tumor on neutrophils and further enhanced metastatic seeding [12] .
Obesity produces an inflammatory state, characterized by macrophages clustered around enlarged hypertrophied, dead, and dying adipocytes from crownlike structures. There are two different type of adipocyte (white or brown). They have different metabolic demands. Due to adipocyte size and taken over the reasonable space, tissues may damage and slow recovery due to chronic inflammation damage which potentially decreases cell proliferation and increases tissue damage. This abnormal condition results in an increase in fibrous tissue and further leads to the development of cancer [13] .
Adipocytes have been suggesting as a major factor in provides as seed and soil to manipulate the microenvironments, may differentiate the normal cells toward to malignancy status (Figure 3) . Thus, adipocytes may contribute significantly to inflammation, immunity, extracellular matrix mechanics, epigenetic or transcriptional regulation, and protein translation in cancers.
Moreover, inflammatory breast cancer (IBC) is a rare, but aggressive type of locally advanced breast cancer. The great portion of IBC cases are also triple negative (TN) patients. The signs of IBC often appear faster than other type of BC, such as redness and swelling which often first treated with antibiotics. Due to the lack of breast lump and symptoms, IBC often misdiagnosis or miss the best treatment time frame.
Most of patients with IBC have advanced-stage disease by the time they begin treatment. The inflammation recruits immune cells which release the cytokines and chemokines which provide seed and soil microenvironment to facilitate metastasis such as Epithelial-to-Mesenchymal transition (EMT) [14] [15] [16] .
Thus, it is it important to increase our understanding of how IBC can be better diagnosed and how biology drives its progression which can lead to improving diagnosis, prognosis with more effective treatment for those with this aggressive disease. 
Conclusion
There is growing evidence correlated obesity with breast cancer in the population health. Studies have demonstrated compelling results to demonstrate the excess adiposity or overweight is associated with inflammation which leads multiple inflammatory signalling pathways to breast cancer development and progression.
There are several non-invasive strategies can approach the anti-inflammatory interventions such as nutritional changes, and pharmacological strategies. It is essential to identify the at-risk population is a key research objective, detect the candidates signalling pathways, and discovery interventions of the wound-like tumor microenvironment (obesity→inflammation→breast cancer axis).
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